Jazz Pharmaceuticals

Últimas noticias

Titulares en el idioma original de la fuente.

• Jazz Pharmaceuticals (JAZZ), The Latest Update Raises A Bigger Question (se abre en una pestaña nueva)

  Simply Wall Street · 2 oct 2026

• After a $1.5M September sale, Jazz Pharmaceuticals (NASDAQ: JAZZ) officer proposes another. (se abre en una pestaña nueva)

  Stock Titan · 1 oct 2026

• Jazz Pharmaceuticals plc (JAZZ) stock price, news, quote and history (se abre en una pestaña nueva)

  Yahoo Finance Australia · 30 sept 2026

• Jazz Pharmaceuticals plc (JAZZ) Stock Price, News, Quote & History (se abre en una pestaña nueva)

  Yahoo! Finance Canada · 30 sept 2026

• Q2 Earnings Outperformers: Jazz Pharmaceuticals (NASDAQ:JAZZ) And The Rest Of The Pharmaceuticals Stocks (se abre en una pestaña nueva)

  Yahoo Finance · 30 sept 2026

• Nuvation stock, Jazz stock gain new Buys at Citi (NUVB:NYSE) (se abre en una pestaña nueva)

  Seeking Alpha · 30 sept 2026

• Jazz Pharmaceuticals Initiated at Buy by Citigroup (se abre en una pestaña nueva)

  Moomoo · 30 sept 2026

• Jazz Pharmaceuticals initiated with a Buy at Citi (se abre en una pestaña nueva)

  tipranks.com · 30 sept 2026

• Citigroup Initiates Jazz Pharmaceuticals at Buy With $325 Price Target (se abre en una pestaña nueva)

  marketscreener.com · 30 sept 2026

• Jazz Pharmaceuticals stock falls 2.43 percent as guidance rises (se abre en una pestaña nueva)

  AD HOC NEWS · 29 sept 2026

• What Comes Next for Jazz Pharmaceuticals (NASDAQ:JAZZ)? (se abre en una pestaña nueva)

  Kalkine Media · 28 sept 2026

• Jazz Pharmaceuticals stock reports record Q2 revenue growth (se abre en una pestaña nueva)

  AD HOC NEWS · 24 sept 2026

• Goldman Sachs initiates Jazz Pharmaceuticals stock with buy rating By Investing.com (se abre en una pestaña nueva)

  Investing.com UK · 24 sept 2026

• Jazz Pharmaceuticals PLC (J7Z.HA) Analyst insights, Price targets and Recommendations (se abre en una pestaña nueva)

  Yahoo Finance UK · 24 sept 2026

• Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026 (se abre en una pestaña nueva)

  TradingView · 23 sept 2026

• Jazz Pharmaceuticals Extends And Reprices $1.895 Billion Term Loan B To 2033 (se abre en una pestaña nueva)

  TradingView · 23 sept 2026

• Five more years to repay its loans: Jazz Pharmaceuticals (JAZZ) also lowers borrowing margins. (se abre en una pestaña nueva)

  Stock Titan · 23 sept 2026

• Jazz Pharmaceuticals (JAZZ) Gains Put Its Valuation Story Back In Focus (se abre en una pestaña nueva)

  Simply Wall Street · 23 sept 2026

• Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands (se abre en una pestaña nueva)

  Yahoo Finance · 20 sept 2026

• Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B (se abre en una pestaña nueva)

  Yahoo Finance · 20 sept 2026

• Ajit Baid Joins Jazz Pharmaceuticals as Executive Director, Head of Marketing – EMD Franchise (se abre en una pestaña nueva)

  hrtoday.in · 18 sept 2026

• Should You Buy Jazz Pharmaceuticals Stock After Its Actio Acquisition? (se abre en una pestaña nueva)

  Yahoo Finance · 18 sept 2026

• Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet (se abre en una pestaña nueva)

  Yahoo Finance · 17 sept 2026

• Jazz Pharmaceuticals at Deutsche Bank 2026 Healthcare Summit: ziihera drives growth (se abre en una pestaña nueva)

  Investing.com · 16 sept 2026

• Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences (se abre en una pestaña nueva)

  PR Newswire · 15 sept 2026

• Jazz Pharmaceuticals Completes $820 Million Upfront Acquisition of Actio Biosciences (se abre en una pestaña nueva)

  Yahoo Finance · 15 sept 2026

• Jazz Pharmaceuticals acquires Actio Biosciences for $820M (September 2026) (se abre en una pestaña nueva)

  Dealroom · 15 sept 2026

• Jazz Pharmaceuticals (JAZZ) Eyes Ziihera Trials In Breast Colorectal And Lung Cancer (se abre en una pestaña nueva)

  Yahoo Finance · 14 sept 2026

• Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says (se abre en una pestaña nueva)

  Yahoo Finance · 11 sept 2026

• UBS Adjusts Jazz Pharmaceuticals PT to $337 From $315, Maintains Buy Rating (se abre en una pestaña nueva)

  Yahoo Finance · 11 sept 2026